Literature DB >> 7286058

Single-dose pharmacokinetics of metoclopramide.

L M Ross-Lee, M J Eadie, W D Hooper, F Bochner.   

Abstract

The time courses of plasma metoclopramide concentrations were followed in six subjects after oral and intravenous single dose administration. Plasma concentration-time data following i. v. administration in each subject were found to fit a two compartment model with a mean terminal half-life of 4.55 h +/- 0.80 h and a mean distribution half-time of 0.35 h +/- 0.09 h. Volumes of distribution were high (3.43 +/- 1.181 . kg-1), and clearances (0.53 +/- 0.191 . kg-1 h-1) approached liver plasma flow. This suggests that metoclopramide occurs at higher concentrations in tissues than in plasma, and that its clearance is probably limited by liver blood flow rather than liver metabolic capacity. The postabsorption decline in metoclopramide plasma levels after oral administration was also biexponential in each subject. The terminal half-life was 5.17 h +/- 0.98 h. Mean volume of distribution and mean clearance were similar to intravenous values (after adjustment for bioavailability). Oral absorption was rapid with peak plasma concentrations being reached at a mean time of 0.93 h. A mean bioavailability of 0.77 was calculated for the six subjects, and it was postulated that this incomplete availability is due to a first-pass effect. The inter-individual variation in the degree of "first-pass' was considerable (0.47--1.14).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7286058     DOI: 10.1007/BF00542101

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  13 in total

1.  Proceedings: In vitro metabolism of metoclopramide.

Authors:  A H Beckett; G Huizing
Journal:  J Pharm Pharmacol       Date:  1975-12       Impact factor: 3.765

2.  Estimation of hepatic first-pass effect of acetaminophen in humans after oral administration.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1975-10       Impact factor: 3.534

3.  The absorption and elimination of metoclopramide in three animal species.

Authors:  O M Bakke; J Segura
Journal:  J Pharm Pharmacol       Date:  1976-01       Impact factor: 3.765

4.  Metoclopramide in the treatment of migraine.

Authors:  S G Matts
Journal:  Practitioner       Date:  1974-06

5.  Transformation and excretion of drugs in biological systems. II. Transformation of metoclopramide in rabbits.

Authors:  T Arita; R Hori; K Ito; K Ichikawa; T Uesugi
Journal:  Chem Pharm Bull (Tokyo)       Date:  1970-08       Impact factor: 1.645

6.  Mlab--a mathematical modeling tool.

Authors:  G D Knott
Journal:  Comput Programs Biomed       Date:  1979-12

7.  Sensitive electron-capture GLC determination of metoclopramide in biological fluids.

Authors:  Y K Tam; J E Axelson
Journal:  J Pharm Sci       Date:  1978-08       Impact factor: 3.534

8.  Pharmacokinetics of metoclopramide intravenously and orally determined by liquid chromatography.

Authors:  C Graffner; P O Lagerström; P Lundborg; O Rönn
Journal:  Br J Clin Pharmacol       Date:  1979-11       Impact factor: 4.335

9.  Metoclopramide metabolism and determination by high-pressure liquid chromatography.

Authors:  L Teng; R B Bruce; L K Dunning
Journal:  J Pharm Sci       Date:  1977-11       Impact factor: 3.534

10.  Electron-capture gas chromatographic assay for metoclopramide in plasma.

Authors:  L M Ross-Lee; M J Eadie; F Bochner; W D Hooper; J H Tyrer
Journal:  J Chromatogr       Date:  1980-08-08
View more
  18 in total

1.  Comparison of the pharmacokinetics of a new 30 mg modified-release tablet formulation of metoclopramide for once-a-day administration versus 10 mg immediate-release tablets: a single and multiple-dose, randomized, open-label, parallel study in healthy male subjects.

Authors:  Roberto Bernardo-Escudero; Rosalba Alonso-Campero; María Teresa de Jesús Francisco-Doce; Myriam Cortés-Fuentes; Miriam Villa-Vargas; Juan Angeles-Uribe
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2012-02-11       Impact factor: 2.441

2.  Pharmacokinetics of metoclopramide in patients with liver cirrhosis.

Authors:  E Magueur; H Hagege; P Attali; E Singlas; J P Etienne; A M Taburet
Journal:  Br J Clin Pharmacol       Date:  1991-02       Impact factor: 4.335

Review 3.  Risks and benefits of drugs used in the management of postoperative nausea and vomiting.

Authors:  Y F Sung
Journal:  Drug Saf       Date:  1996-03       Impact factor: 5.606

4.  The effect of metoclopramide in capsule enteroscopy.

Authors:  Nuno Almeida; Pedro Figueiredo; Paulo Freire; Sandra Lopes; Clotilde Lérias; Hermano Gouveia; Maximino Correia Leitão
Journal:  Dig Dis Sci       Date:  2009-01-29       Impact factor: 3.199

Review 5.  Clinical pharmacokinetics of drugs used in the treatment of gastrointestinal diseases (Part II).

Authors:  K Lauritsen; L S Laursen; J Rask-Madsen
Journal:  Clin Pharmacokinet       Date:  1990-08       Impact factor: 6.447

6.  Bioavailability of intranasal metoclopramide.

Authors:  M J Ward; D C Buss; J Ellershaw; A Nash; P A Routledge
Journal:  Br J Clin Pharmacol       Date:  1989-11       Impact factor: 4.335

7.  Oral bioavailability of high-dose metoclopramide.

Authors:  W B Taylor; D N Bateman
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Antiemetic effect and pharmacokinetics of high dose metoclopramide in cancer patients treated with cisplatin-containing chemotherapy regimens.

Authors:  H Havsteen; H Nielsen; M Kjaer
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

9.  High dose metoclopramide-preliminary pharmacokinetic studies.

Authors:  W D Taylor; D N Bateman
Journal:  Br J Clin Pharmacol       Date:  1983-09       Impact factor: 4.335

Review 10.  Pharmacokinetics of high-dose metoclopramide in cancer patients.

Authors:  E M McGovern; J Grevel; S M Bryson
Journal:  Clin Pharmacokinet       Date:  1986 Nov-Dec       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.